Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells

2004 ◽  
Vol 86 (6) ◽  
pp. 1153-1160 ◽  
Author(s):  
Valérie Gangji ◽  
Jean-Philippe Hauzeur ◽  
Celso Matos ◽  
Viviane De Maertelaer ◽  
Michel Toungouz ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Autologous Bone ◽  
Marrow Cells

Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: Five-year follow-up

Bone ◽  
2007 ◽  
Vol 40 (6) ◽  
pp. S46-S47 ◽  
Author(s):  
V. Gangji ◽  
M. Toungouz ◽  
M. Lambermont ◽  
E. Bastianelli ◽  
J. Hauzeur
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Autologous Bone ◽  
Marrow Cells

Development of cell therapy using autologous bone marrow cells for liver cirrhosis

2005 ◽  
Vol 38 (4) ◽  
pp. 197-202 ◽  
Author(s):  
Isao Sakaida ◽  
Shuji Terai ◽  
Hiroshi Nishina ◽  
Kiwamu Okita
Keyword(s):  
Bone Marrow ◽  
Liver Cirrhosis ◽  
Cell Therapy ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Autologous Bone ◽  
Marrow Cells

The Safety and Feasibility of the Local Implantation of Autologous Bone Marrow Cells for Ischemic Heart Disease

2003 ◽  
Vol 18 ◽  
pp. S69-S75 ◽  
Author(s):  
Tao-Sheng Li ◽  
Kimikazu Hamano ◽  
Ken Hirata ◽  
Toshiro Kobayashi ◽  
Masahiko Nishida
Keyword(s):  
Bone Marrow ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Ischemic Heart ◽  
Autologous Bone ◽  
Marrow Cells

scholarly journals Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells

Rheumatology ◽  
2008 ◽  
Vol 47 (5) ◽  
pp. 591-596 ◽  
Author(s):  
T. Asada ◽  
T. Kushida ◽  
M. Umeda ◽  
K. Oe ◽  
H. Matsuya ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Autologous Bone ◽  
Marrow Cells

Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation

Blood ◽  
1987 ◽  
Vol 70 (5) ◽  
pp. 1490-1494 ◽  
Author(s):  
RJ Jones ◽  
M Zuehlsdorf ◽  
SD Rowley ◽  
J Hilton ◽  
GW Santos ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Transplantation ◽  
Marrow Transplantation ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow Transplantation ◽  
Tumor Cell Line ◽  
Autologous Bone Marrow ◽  
Incubation Mixture ◽  
Autologous Bone ◽  
Marrow Cells

Abstract We examined the effects of varying incubation conditions on the in vitro activity of 4-hydroperoxycyclophosphamide (4HC). 4HC activity against CFU-GM and against the K562 tumor cell line decreased with increasing the RBC concentration of the incubation mixture. Increasing the concentration of nucleated bone marrow cells in the incubation mixture also decreased the 4HC activity. Evaluation of 53 consecutive patients undergoing autologous bone marrow transplantation (BMT) revealed that the incubation RBC concentration during clinical purging showed a similar effect on CFU-GM recovery. Aldehyde dehydrogenase content of RBCs and nucleated marrow cells appears to be the cause of the inhibition of 4HC activity. Although there was no difference in individual CFU-GM sensitivity to 4HC among normals, previously treated patients undergoing autologous BMT showed significant variability in CFU-GM sensitivity to 4HC. The combined effects of incubation RBC concentration and individual patient 4HC sensitivity appear to account for most of the variability in CFU-GM recovery and speed of hematologic recovery after clinical purging with 4HC.

Sign in / Sign up

Export Citation Format

Share Document